Previous studies have found that the use of hypoglycemic drugs like sulfonylureas and insulin may cause hypoglycemia during hemodialysis [32], but the hypoglycemic drugs did not enter the risk prediction model of hypoglycemia during hemodialysis for the patients with DN in this study. Here, INS is linked to liver dysplastic nodule.